NCT03158896View on ClinicalTrials.gov

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Acute Graft Versus Host Disease
Interventions
BIOLOGICAL

MSCTC-0010 Dose Escalation

"Cohort 1: 2.0 × 106 cells per kilogram (cells/kg) body weight, given on day 0 and on day 7 in Participants having de novo High Risk Acute or Steroid Refractory Acute Graft Versus Host Disease (HR/SR aGvHD)~Cohort 2: 10 × 106 cells/kg of body weight, given on day 0 and on day 7 in Participants having de novo HR/SR aGvHD"

Trial Locations (1)

66160

RECRUITING

Kansas University Cancer Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER